AQR Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.1K | Buy |
26,382
+23,483
| +810% | +$44.6K | ﹤0.01% | 3237 |
|
|
2025
Q1 | $20.6K | Buy |
2,899
+2,004
| +224% | +$14.2K | ﹤0.01% | 3126 |
|
|
2024
Q4 | $19.7K | Sell |
895
-22,962
| -96% | -$505K | ﹤0.01% | 2847 |
|
|
2024
Q3 | $479K | Buy |
23,857
+9,722
| +69% | +$195K | ﹤0.01% | 2193 |
|
|
2024
Q2 | $246K | Buy |
14,135
+12,937
| +1,080% | +$225K | ﹤0.01% | 2346 |
|
|
2024
Q1 | $49.9K | Sell |
1,198
-4,280
| -78% | -$178K | ﹤0.01% | 2375 |
|
|
2023
Q4 | $138K | Buy |
5,478
+3,435
| +168% | +$86.4K | ﹤0.01% | 2256 |
|
|
2023
Q3 | $66.8K | Buy |
+2,043
| New | +$66.8K | ﹤0.01% | 2268 |
|